Rank #1134EBS

Emergent BioSolutions Inc.

$10.99

1.95% (Daily)

Market Cap

$586.33M

Revenue

$788.90M

Rank by MCap

#1134

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Joseph C. Papa Jr., M.B.A., R.Ph.

Headquarters

Gaithersburg, MD

Employees

900

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax...